Literature DB >> 2199486

Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins.

S R Coates1, A J Harris, D L Parkes, C M Smith, H L Liu, R W Akita, M M Ferrer, E K Sampson, J W Brandis, M X Sliwkowski.   

Abstract

Three proteins (env, gag, and tax) encoded by the human T-cell leukemia virus type I (HTLV-I) genome were cloned and expressed in Escherichia coli. The env protein contained a substantial part of the gp46 domain and a majority of the p21e domain. The gag protein contained all of p24 and portions of p19 and p15. In addition to these two structural proteins, a full-length tax (p40X) construct was obtained. All three recombinant proteins were purified to near homogeneity. When used in an immunoblot assay, the three recombinant proteins detected antibodies in more HTLV-I antibody-positive patient sera than did the corresponding native proteins. Antibodies to at least two of these three different gene products were detected in 98.4% of adult T-cell leukemia patients, 100% of HTLV-I-associated myelopathy patients, 97.4% of asymptomatic carriers, and 94% of uncharacterized HTLV-I-positive patients. Antibody to recombinant tax was found in 4.9% of adult T-cell leukemia patients, whereas antibody to recombinant env could not be detected. These recombinant proteins from three different gene products may be useful in detecting or confirming the presence of antibodies to HTLV-I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199486      PMCID: PMC267892          DOI: 10.1128/jcm.28.6.1139-1142.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II.

Authors:  D J Slamon; K Shimotohno; M J Cline; D W Golde; I S Chen
Journal:  Science       Date:  1984-10-05       Impact factor: 47.728

4.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

5.  Comparison of immunofluorescence, enzyme immunoassay, and Western blot (immunoblot) methods for detection of antibody to human T-cell leukemia virus type I.

Authors:  D Gallo; M N Hoffman; C K Cossen; J L Diggs; J W Hurst; L M Penning
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

6.  Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  D S Burke; R R Redfield; P Putman; S S Alexander
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

7.  C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.

Authors:  T J Palker; R M Scearce; T D Copeland; S Oroszlan; B F Haynes
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  Characterization of a novel HTLV-infected cell line.

Authors:  H P Koeffler; I S Chen; D W Golde
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

9.  Detection of antibodies to human T-lymphotropic virus type 1 (HTLV-1).

Authors:  C T Fang; A E Williams; S G Sandler; D J Slamon; B J Poiesz
Journal:  Transfusion       Date:  1988 Mar-Apr       Impact factor: 3.157

10.  High risk of mother-to-child transmission of HTLV-I in p40tax antibody-positive mothers.

Authors:  T Sawada; J Tohmatsu; T Obara; A Koide; S Kamihira; M Ichimaru; S Kashiwagi; W Kajiyama; N Matsumura; K Kinoshita
Journal:  Jpn J Cancer Res       Date:  1989-06
View more
  5 in total

1.  Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay.

Authors:  H Miyakoshi; M Sugimoto; H Igarashi; H Honda; R Fujino; M Mizukoshi
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

2.  Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

Authors:  R B Lal; W Heneine; D L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.

Authors:  R B Lal; S Brodine; J Kazura; E Mbidde-Katonga; R Yanagihara; C Roberts
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

4.  Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.

Authors:  D L Rudolph; J Yee; J Mone; S K Foung; J J Lipka; G R Reyes; K Hadlock; L Chan; F Villinger; M D Lairmore
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1.

Authors:  Pooja Jain; Jaya Ahuja; Zafar K Khan; Saori Shimizu; Olimpia Meucci; Stephen R Jennings; Brian Wigdahl
Journal:  J Leukoc Biol       Date:  2007-04-18       Impact factor: 4.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.